Alveolar Soft Tissue Sarcoma: Correlation of MRI Features With Histological Grading and Patient Prognosis
Background Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival. Objective To evaluate MRI features associated with Grade III ASPS...
Saved in:
| Published in | Journal of magnetic resonance imaging Vol. 61; no. 3; pp. 1482 - 1491 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hoboken, USA
John Wiley & Sons, Inc
01.03.2025
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1053-1807 1522-2586 1522-2586 |
| DOI | 10.1002/jmri.29545 |
Cover
| Abstract | Background
Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival.
Objective
To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis.
Study Type
Retrospective analysis.
Subjects
Sixty‐seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow‐up and survival analysis on 50 patients.
Field Strength/Sequence
A 3.0 T, T1WI‐FSE, T2WI‐FSE, DWI‐EPI, DCE‐MRI (gradient echo).
Assessment
MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time‐intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high‐grade.
Statistical Tests
The chi‐square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high‐grade tumors. The Kaplan–Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features.
Results
Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high‐grade ASPS. Tumor necrosis was an independent factors associated with local relapse‐free survival (odds ratio [OR], 3.88). TIC type was associated with 5‐year survival rate (OR, 2.80) and local relapse‐free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5‐year survival (OR, 4.00), local relapse‐free survival (OR, 5.58), and local relapse‐free survival (OR, 4.84).
Data Conclusion
MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis.
Evidence Level
4
Technical Efficacy
Stage 5 |
|---|---|
| AbstractList | Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival.BACKGROUNDAlveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival.To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis.OBJECTIVETo evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis.Retrospective analysis.STUDY TYPERetrospective analysis.Sixty-seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow-up and survival analysis on 50 patients.SUBJECTSSixty-seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow-up and survival analysis on 50 patients.A 3.0 T, T1WI-FSE, T2WI-FSE, DWI-EPI, DCE-MRI (gradient echo).FIELD STRENGTH/SEQUENCEA 3.0 T, T1WI-FSE, T2WI-FSE, DWI-EPI, DCE-MRI (gradient echo).MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time-intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high-grade.ASSESSMENTMRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time-intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high-grade.The chi-square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high-grade tumors. The Kaplan-Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features.STATISTICAL TESTSThe chi-square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high-grade tumors. The Kaplan-Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features.Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high-grade ASPS. Tumor necrosis was an independent factors associated with local relapse-free survival (odds ratio [OR], 3.88). TIC type was associated with 5-year survival rate (OR, 2.80) and local relapse-free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5-year survival (OR, 4.00), local relapse-free survival (OR, 5.58), and local relapse-free survival (OR, 4.84).RESULTSTumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high-grade ASPS. Tumor necrosis was an independent factors associated with local relapse-free survival (odds ratio [OR], 3.88). TIC type was associated with 5-year survival rate (OR, 2.80) and local relapse-free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5-year survival (OR, 4.00), local relapse-free survival (OR, 5.58), and local relapse-free survival (OR, 4.84).MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis.DATA CONCLUSIONMRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis.4 TECHNICAL EFFICACY: Stage 5.EVIDENCE LEVEL4 TECHNICAL EFFICACY: Stage 5. BackgroundAlveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival.ObjectiveTo evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis.Study TypeRetrospective analysis.SubjectsSixty‐seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow‐up and survival analysis on 50 patients.Field Strength/SequenceA 3.0 T, T1WI‐FSE, T2WI‐FSE, DWI‐EPI, DCE‐MRI (gradient echo).AssessmentMRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time‐intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high‐grade.Statistical TestsThe chi‐square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high‐grade tumors. The Kaplan–Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features.ResultsTumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high‐grade ASPS. Tumor necrosis was an independent factors associated with local relapse‐free survival (odds ratio [OR], 3.88). TIC type was associated with 5‐year survival rate (OR, 2.80) and local relapse‐free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5‐year survival (OR, 4.00), local relapse‐free survival (OR, 5.58), and local relapse‐free survival (OR, 4.84).Data ConclusionMRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis.Evidence Level4Technical EfficacyStage 5 Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival. To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis. Retrospective analysis. Sixty-seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow-up and survival analysis on 50 patients. A 3.0 T, T1WI-FSE, T2WI-FSE, DWI-EPI, DCE-MRI (gradient echo). MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time-intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high-grade. The chi-square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high-grade tumors. The Kaplan-Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features. Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high-grade ASPS. Tumor necrosis was an independent factors associated with local relapse-free survival (odds ratio [OR], 3.88). TIC type was associated with 5-year survival rate (OR, 2.80) and local relapse-free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5-year survival (OR, 4.00), local relapse-free survival (OR, 5.58), and local relapse-free survival (OR, 4.84). MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis. 4 TECHNICAL EFFICACY: Stage 5. Background Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival. Objective To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis. Study Type Retrospective analysis. Subjects Sixty‐seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow‐up and survival analysis on 50 patients. Field Strength/Sequence A 3.0 T, T1WI‐FSE, T2WI‐FSE, DWI‐EPI, DCE‐MRI (gradient echo). Assessment MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time‐intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high‐grade. Statistical Tests The chi‐square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high‐grade tumors. The Kaplan–Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features. Results Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high‐grade ASPS. Tumor necrosis was an independent factors associated with local relapse‐free survival (odds ratio [OR], 3.88). TIC type was associated with 5‐year survival rate (OR, 2.80) and local relapse‐free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5‐year survival (OR, 4.00), local relapse‐free survival (OR, 5.58), and local relapse‐free survival (OR, 4.84). Data Conclusion MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis. Evidence Level 4 Technical Efficacy Stage 5 |
| Author | Wang, Yuanyuan Xie, Deshun Chen, Xuejun Meng, Fan Shan, Dongqiu Zhang, Renzhi Xu, Chunmiao Du, Xinhui Fang, Shaobo Yuan, Junhui |
| Author_xml | – sequence: 1 givenname: Junhui surname: Yuan fullname: Yuan, Junhui organization: The First Affiliated Hospital of Fujian Medical University – sequence: 2 givenname: Deshun surname: Xie fullname: Xie, Deshun organization: Heze Municipal Hospital – sequence: 3 givenname: Shaobo orcidid: 0000-0003-0645-5463 surname: Fang fullname: Fang, Shaobo organization: Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Academy of Medical Sciences, Zhengzhou University – sequence: 4 givenname: Fan surname: Meng fullname: Meng, Fan organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital – sequence: 5 givenname: Dongqiu surname: Shan fullname: Shan, Dongqiu organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital – sequence: 6 givenname: Yuanyuan surname: Wang fullname: Wang, Yuanyuan organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital – sequence: 7 givenname: Xinhui surname: Du fullname: Du, Xinhui organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital – sequence: 8 givenname: Chunmiao orcidid: 0000-0003-4064-5447 surname: Xu fullname: Xu, Chunmiao organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital – sequence: 9 givenname: Renzhi surname: Zhang fullname: Zhang, Renzhi email: zhangrenzhi7790@126.com organization: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College – sequence: 10 givenname: Xuejun orcidid: 0000-0001-6124-7312 surname: Chen fullname: Chen, Xuejun email: chenxuejun1967@163.com organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39037329$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90U1P3DAQBmCroiqw7YUfUFnqBSEFxl9J3Bta8VVRgQoVR8tJJluvHBvspBX_nmyX9tBDT_bhmdHofffJTogBCTlgcMwA-Ml6SO6YayXVG7LHFOcFV3W5M_9BiYLVUO2S_ZzXAKC1VO_IrtAgKsH1HnGn_idGbxO9i_1I713OE9I7m9o42M90GVNCb0cXA409_frtip6jHaeEmT648Qe9dHmMPq5caz29SLZzYUVt6OjtPIRhpLcprkLMLr8nb3vrM354fRfk-_nZ_fKyuL65uFqeXhetYKUqqr6sARvUpZUla_quEtBIzqQQDXSyLkUnsWolgCo5qlJ1lrUNY7q3uq2UFAtyuN37mOLThHk0g8stem8DxikbAbXgTNcgZvrpH7qOUwrzdWa-RXIhNgkuyMdXNTUDduYxucGmZ_MnxBkcbUGbYs4J-7-Egdk0ZDYNmd8NzZht8S_n8fk_0nyZ097OvADenZEs |
| Cites_doi | 10.1177/1758834017705588 10.1016/j.diii.2018.02.005 10.1002/jso.24183 10.1148/radiol.14131871 10.2174/1573405616999200729152135 10.5858/2006-130-1448-GOSTSR 10.1007/s00330-018-5845-9 10.1016/j.humpath.2016.06.008 10.1016/S1470-2045(17)30334-0 10.1002/jmri.25791 10.1056/NEJMoa2303383 10.1002/jmri.26659 10.21037/qims-23-743 10.1148/radiol.2019181659 10.1002/jmri.27954 10.1016/j.prp.2021.153562 10.1007/s00330-017-4912-y 10.1016/j.ejca.2016.09.030 10.2967/jnumed.109.074229 10.3390/clinpract13060123 10.1159/000477443 10.1159/000071199 10.1007/s00256-024-04598-3 10.2214/AJR.14.12462 10.1016/j.ejrad.2016.05.003 10.1001/jamaoncol.2018.4490 10.1097/PAS.0000000000000867 |
| ContentType | Journal Article |
| Copyright | 2024 International Society for Magnetic Resonance in Medicine. 2025 International Society for Magnetic Resonance in Medicine |
| Copyright_xml | – notice: 2024 International Society for Magnetic Resonance in Medicine. – notice: 2025 International Society for Magnetic Resonance in Medicine |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 K9. P64 7X8 |
| DOI | 10.1002/jmri.29545 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1522-2586 |
| EndPage | 1491 |
| ExternalDocumentID | 39037329 10_1002_jmri_29545 JMRI29545 |
| Genre | researchArticle Journal Article |
| GrantInformation_xml | – fundername: Medical Science and Technology Tackling Programme of Henan Province (Joint Co‐construction) Project funderid: LHGJ20190662 – fundername: Medical Science and Technology Tackling Programme of Henan Province (Joint Co-construction) Project grantid: LHGJ20190662 |
| GroupedDBID | --- -DZ .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HDBZQ HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V8K V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 ZXP ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY CITATION AGQPQ CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 K9. P64 7X8 |
| ID | FETCH-LOGICAL-c3165-7f680ebe96a461bfd730b421433b0d4863d4e7c400562e565da1cb119fa9c7543 |
| IEDL.DBID | DR2 |
| ISSN | 1053-1807 1522-2586 |
| IngestDate | Fri Sep 05 12:42:45 EDT 2025 Tue Oct 07 06:08:32 EDT 2025 Thu Apr 24 02:13:28 EDT 2025 Wed Oct 01 04:37:28 EDT 2025 Fri Feb 07 09:41:49 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | magnetic resonance imaging histological grading Alveolar Soft Part Sarcoma prognosis |
| Language | English |
| License | 2024 International Society for Magnetic Resonance in Medicine. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3165-7f680ebe96a461bfd730b421433b0d4863d4e7c400562e565da1cb119fa9c7543 |
| Notes | Junhui Yuan, Deshun Xie, and Shaobo Fang contributed consistently to this article. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-4064-5447 0000-0003-0645-5463 0000-0001-6124-7312 |
| PMID | 39037329 |
| PQID | 3164233105 |
| PQPubID | 1006400 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_3083219803 proquest_journals_3164233105 pubmed_primary_39037329 crossref_primary_10_1002_jmri_29545 wiley_primary_10_1002_jmri_29545_JMRI29545 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | March 2025 |
| PublicationDateYYYYMMDD | 2025-03-01 |
| PublicationDate_xml | – month: 03 year: 2025 text: March 2025 |
| PublicationDecade | 2020 |
| PublicationPlace | Hoboken, USA |
| PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Nashville |
| PublicationSubtitle | JMRI |
| PublicationTitle | Journal of magnetic resonance imaging |
| PublicationTitleAlternate | J Magn Reson Imaging |
| PublicationYear | 2025 |
| Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
| References | 2017; 40 2017; 41 2023; 13 2019; 291 2019; 5 2019; 50 2021; 225 2017; 27 2006; 130 2023; 389 2024; 53 2014; 272 2020; 11 2017; 9 2016; 56 2018; 47 2017; 70 2021; 17 2016; 113 2016; 85 2019; 29 2017; 18 2022; 55 2018; 99 2003; 65 2010; 51 2014; 203 e_1_2_6_10_1 Lv C (e_1_2_6_29_1) 2023; 13 e_1_2_6_19_1 Spinnato P (e_1_2_6_14_1) 2020; 11 e_1_2_6_13_1 e_1_2_6_11_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
| References_xml | – volume: 9 start-page: 415 year: 2017 end-page: 429 article-title: Neoadjuvant chemotherapy in soft tissue sarcomas: Latest evidence and clinical implications publication-title: Ther Adv Med Oncol – volume: 99 start-page: 473 year: 2018 end-page: 481 article-title: Perfusion MR imaging at 3‐tesla: Can it predict tumor grade and histologic necrosis rate of musculoskeletal sarcoma? publication-title: Diagn Interv Imaging – volume: 29 start-page: 4485 year: 2019 end-page: 4494 article-title: Conventional MR and diffusion‐weighted imaging of musculoskeletal soft tissue malignancy: Correlation with histologic grading publication-title: Eur Radiol – volume: 53 start-page: 1343 year: 2024 end-page: 1357 article-title: Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) in differentiation of soft tissue sarcoma from benign lesions: A systematic review of literature publication-title: Skeletal Radiol – volume: 56 start-page: 147 year: 2016 end-page: 154 article-title: Federation nationale des centers de lutte contre le cancer grading of soft tissue sarcomas on needle core biopsies using surrogate markers publication-title: Hum Pathol – volume: 18 start-page: 812 year: 2017 end-page: 822 article-title: Histotype‐tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high‐risk soft‐tissue sarcomas (ISG‐STS 1001): An international, open‐label, randomised, controlled, phase 3, multicentre trial publication-title: Lancet Oncol – volume: 41 start-page: 923 year: 2017 end-page: 931 article-title: The adequacy of core biopsy in the assessment of smooth muscle neoplasms of soft tissues: Implications for treatment and prognosis publication-title: Am J Surg Pathol – volume: 389 start-page: 911 year: 2023 end-page: 921 article-title: Atezolizumab for advanced alveolar soft part sarcoma publication-title: N Engl J Med – volume: 130 start-page: 1448 year: 2006 end-page: 1453 article-title: Grading of soft tissue sarcomas: Review and update publication-title: Arch Pathol Lab Med – volume: 11 start-page: 1524 year: 2020 end-page: 1529 article-title: MRI features as prognostic factors in myxofibrosarcoma: Proposal of MRI grading system publication-title: Acad Radiol – volume: 5 start-page: 254 year: 2019 end-page: 260 article-title: Diagnosis, prognosis, and treatment of alveolar soft‐part sarcoma: A review publication-title: JAMA Oncol – volume: 27 start-page: 5024 year: 2017 end-page: 5033 article-title: Multiparametric voxel‐based analyses of standardized uptake values and apparent diffusion coefficients of soft‐tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results publication-title: Eur Radiol – volume: 70 start-page: 1 year: 2017 end-page: 11 article-title: (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair publication-title: Eur J Cancer – volume: 85 start-page: 1336 year: 2016 end-page: 1344 article-title: Current utilities of imaging in grading musculoskeletal soft tissue sarcomas publication-title: Eur J Radiol – volume: 55 start-page: 1357 year: 2022 end-page: 1375 article-title: An update in imaging evaluation of histopathological grade of soft tissue sarcomas using structural and quantitative imaging and radiomics publication-title: J Magn Reson Imaging – volume: 17 start-page: 217 year: 2021 end-page: 224 article-title: Myxofibrosarcoma: Clinical and prognostic value of MRI features publication-title: Curr Med Imaging – volume: 50 start-page: 11 year: 2019 end-page: 27 article-title: Magnetic resonance imaging biomarkers in musculoskeletal soft tissue tumors: Review of conventional features and focus on nonmorphologic imaging publication-title: J Magn Reson Imaging – volume: 13 start-page: 1369 year: 2023 end-page: 1382 article-title: Imaging features of alveolar soft part sarcoma: Single institution experience and literature review publication-title: Clin Pract – volume: 272 start-page: 192 year: 2014 end-page: 201 article-title: Can MR imaging be used to predict tumor grade in soft‐tissue sarcoma? publication-title: Radiology – volume: 225 year: 2021 article-title: Ki‐67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult‐soft tissue sarcomas. An international collaborative study publication-title: Pathol Res Pract – volume: 47 start-page: 829 year: 2018 end-page: 840 article-title: Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions publication-title: J Magn Reson Imaging – volume: 51 start-page: 1174 year: 2010 end-page: 1181 article-title: Correlation between glycolytic phenotype and tumor grade in soft‐tissue sarcomas by 18F‐FDG PET publication-title: J Nucl Med – volume: 291 start-page: 710 year: 2019 end-page: 721 article-title: Soft‐tissue sarcomas: Assessment of MRI features correlating with histologic grade and patient outcome publication-title: Radiology – volume: 65 start-page: 7 year: 2003 end-page: 13 article-title: Alveolar soft part sarcoma in Japan: Multi‐institutional study of 57 patients from the Japanese musculoskeletal oncology group publication-title: Oncology – volume: 40 start-page: 580 year: 2017 end-page: 585 article-title: Magnetic resonance features and characteristic vascular pattern of alveolar soft‐part sarcoma publication-title: Oncol Res Treat – volume: 203 start-page: 1345 year: 2014 end-page: 1352 article-title: Imaging features of alveolar soft‐part sarcoma: A report from Children's Oncology Group Study ARST0332 publication-title: AJR Am J Roentgenol – volume: 113 start-page: 581 year: 2016 end-page: 586 article-title: Prognostic factors in alveolar soft part sarcoma: A SEER analysis publication-title: J Surg Oncol – volume: 13 start-page: 7269 year: 2023 end-page: 7280 article-title: The dynamic contrast enhanced‐magnetic resonance imaging and diffusion‐weighted imaging features of alveolar soft part sarcoma publication-title: Quant Imaging Med Surg – ident: e_1_2_6_9_1 doi: 10.1177/1758834017705588 – ident: e_1_2_6_24_1 doi: 10.1016/j.diii.2018.02.005 – ident: e_1_2_6_5_1 doi: 10.1002/jso.24183 – ident: e_1_2_6_18_1 doi: 10.1148/radiol.14131871 – ident: e_1_2_6_27_1 doi: 10.2174/1573405616999200729152135 – ident: e_1_2_6_11_1 doi: 10.5858/2006-130-1448-GOSTSR – ident: e_1_2_6_25_1 doi: 10.1007/s00330-018-5845-9 – ident: e_1_2_6_7_1 doi: 10.1016/j.humpath.2016.06.008 – ident: e_1_2_6_8_1 doi: 10.1016/S1470-2045(17)30334-0 – ident: e_1_2_6_17_1 doi: 10.1002/jmri.25791 – ident: e_1_2_6_3_1 doi: 10.1056/NEJMoa2303383 – ident: e_1_2_6_13_1 doi: 10.1002/jmri.26659 – volume: 13 start-page: 7269 year: 2023 ident: e_1_2_6_29_1 article-title: The dynamic contrast enhanced‐magnetic resonance imaging and diffusion‐weighted imaging features of alveolar soft part sarcoma publication-title: Quant Imaging Med Surg doi: 10.21037/qims-23-743 – ident: e_1_2_6_20_1 doi: 10.1148/radiol.2019181659 – ident: e_1_2_6_6_1 doi: 10.1002/jmri.27954 – ident: e_1_2_6_23_1 doi: 10.1016/j.prp.2021.153562 – ident: e_1_2_6_19_1 doi: 10.1007/s00330-017-4912-y – ident: e_1_2_6_10_1 doi: 10.1016/j.ejca.2016.09.030 – ident: e_1_2_6_16_1 doi: 10.2967/jnumed.109.074229 – ident: e_1_2_6_26_1 doi: 10.3390/clinpract13060123 – ident: e_1_2_6_28_1 doi: 10.1159/000477443 – ident: e_1_2_6_4_1 doi: 10.1159/000071199 – ident: e_1_2_6_21_1 doi: 10.1007/s00256-024-04598-3 – volume: 11 start-page: 1524 year: 2020 ident: e_1_2_6_14_1 article-title: MRI features as prognostic factors in myxofibrosarcoma: Proposal of MRI grading system publication-title: Acad Radiol – ident: e_1_2_6_22_1 doi: 10.2214/AJR.14.12462 – ident: e_1_2_6_15_1 doi: 10.1016/j.ejrad.2016.05.003 – ident: e_1_2_6_2_1 doi: 10.1001/jamaoncol.2018.4490 – ident: e_1_2_6_12_1 doi: 10.1097/PAS.0000000000000867 |
| SSID | ssj0009945 |
| Score | 2.4652805 |
| Snippet | Background
Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor... Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can... BackgroundAlveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1482 |
| SubjectTerms | Adolescent Adult Aged Alveolar Soft Part Sarcoma Bone tumors Child Edema Evaluation Female Field strength Hazard assessment Hazard identification Heterogeneity histological grading Humans Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Medical prognosis Metastases Middle Aged Necrosis Neoplasm Grading Prognosis Regression models Retrospective Studies Sarcoma Sarcoma, Alveolar Soft Part - diagnostic imaging Sarcoma, Alveolar Soft Part - pathology Soft tissue sarcoma Soft tissues Statistical analysis Statistical models Statistical tests Survival Survival Analysis Tumors Young Adult |
| Title | Alveolar Soft Tissue Sarcoma: Correlation of MRI Features With Histological Grading and Patient Prognosis |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.29545 https://www.ncbi.nlm.nih.gov/pubmed/39037329 https://www.proquest.com/docview/3164233105 https://www.proquest.com/docview/3083219803 |
| Volume | 61 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1053-1807 databaseCode: DR2 dateStart: 19990101 customDbUrl: isFulltext: true eissn: 1522-2586 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009945 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB5CHkJe2lxtNxcK6VPAG-tYWQp5CSEnbAk5aF6KkWyZbA477JGH_PqMZO8uaSGQvhkkI3lGM_rGGn0D8FMkygmV06ijaR55yu7IFkpGiCWYNJYlhfS3kbu_5OmNOL_t3M7A_vguTM0PMfnh5i0j-Gtv4MYOdqekofdP_V7bn1L5G-aUyxBPXU65o7QOFYoRP_CIqjiZcJOy3emr73ejfyDme8Qatpzjr_BnPNk60-ShPRradvb6F4_j_37NAnxpsCg5qBfPIsy4cgnmus1p-zL0Dh5fnA99yRU6a3IddESu0DSqJ7NHDn1hjzqVjlQF6V6eEQ8oRxjAk9-94R0JFCSNbyUn_ZCtT0yZk4uazJVc9Cuf59cbrMDN8dH14WnUlGaIMk5lJ0IVqhj1r6URktoiR0dhBUPwxW2cCyV5LlySCc80yhyCxtzQzFKqC6OzpCP4N5gtq9L9AKKMyGOpWSGxv0kwwHGFJyUUUlEjTdyC7bGK0ueagSOtuZZZ6qWWBqm1YH2svbSxwkGKU0W0iAAWm7cmzWg__lDElK4aYZ_Y12rSKuYt-F5rfTIM1zFPONMt2Am6-2D89BylHJ5WP9N5DeaZLygcktrWYXbYH7kNRDlDuxlW8xuzqPYz |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVgIu0AItCwWM4ISUbfyIY3OrKsr2sVXVbkVvkZM46gJN0D448OuZcdJdlUpIcItkR05mPONv7PE3AO9VarwyJY8Sy8uIKLujvDI6QiwhtMtFWmm6jTw80YMLdXiZXHa5OXQXpuWHWGy4kWUEf00GThvSO0vW0K_Xk3GfjqmSe7CmNAYqhInOluxR1oYaxYggZMRNnC7YScXO8t3b69EdkHkbs4ZFZ_9xW1l1GrgKKdfkW38-y_vFrz-YHP_7f9bhUQdH2W47fzZgxddP4P6wO3B_CuPd7z89Rb_sHP01GwU1sXO0jubafWR7VNujzaZjTcWGZweMMOUcY3j2ZTy7YoGFpHOv7PMkJOwzV5fstOVzZaeThlL9xtNncLH_abQ3iLrqDFEhuU4i1KKJcQpY7ZTmeVWir8iVQPwl87hURstS-bRQRDYqPOLG0vEi59xWzhZpouQmrNZN7Z8DM06Vsbai0tjfpRjj-Ip4CZU23GkX9-DdjY6yHy0JR9bSLYuMpJYFqfVg-0Z9WWeI0ww_FQEjYlhsfrtoRhOicxFX-2aOfWIq12RNLHuw1ap9MYy0sUylsD34EJT3l_GzQ5RyeHrxL53fwIPBaHicHR-cHL2Eh4LqC4cct21YnU3m_hWCnln-Okzt3yd7-lQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFLZaKqFegG4wQFtX7alShniJY3ND0GFpB41YVG6REztiWBI0C4f--r7nhBlRpErtLZIdOfHze_5sf_4eIV9kqr3UjkWJYS5Cye4oL7WKAEtwZXOelgpvI_eP1cG5PLpILlpuDt6FafQhZhtu6BkhXqOD-ztXbs1VQ69uR8MuHlMlz8kLmRiNjL69k7l6lDEhRzEgCBExHaczdVK-NX_38Xz0BGQ-xqxh0uktN5lVx0GrELkm193pJO8Wv_5Qcvzv_1khSy0cpTvN-HlFnvnqNVnstwfub8hw5-be4-qXnkK8pmfBTPQUvKO-tdt0F3N7NGw6Wpe0f3JIEVNOYQ1Pfw4nlzSokLThle6PAmGf2srRQaPnSgejGql-w_Fbct77drZ7ELXZGaJCMJVEYEUdwxAwykrF8tJBrMglB_wl8thJrYSTPi0kio1yD7jRWVbkjJnSmiJNpHhHFqq68muEaitdrAwvFdS3KaxxfIm6hFJpZpWNO-Tzg42yu0aEI2vklnmGvZaFXuuQzQfzZa0jjjP4VACMgGGh-NOsGFwIz0Vs5esp1IkxXZPRseiQ1cbss2aEiUUquOmQr8F4f2k_O4JeDk_r_1L5I1kc7PWyH4fH3zfIS47phQPFbZMsTEZT_x4wzyT_EEb2b9b0-dg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alveolar+Soft+Tissue+Sarcoma%3A+Correlation+of+MRI+Features+With+Histological+Grading+and+Patient+Prognosis&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Yuan%2C+Junhui&rft.au=Xie%2C+Deshun&rft.au=Fang%2C+Shaobo&rft.au=Fan%2C+Meng&rft.date=2025-03-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1053-1807&rft.eissn=1522-2586&rft.volume=61&rft.issue=3&rft.spage=1482&rft.epage=1491&rft_id=info:doi/10.1002%2Fjmri.29545&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon |